State Medicaid formularies demonstrate significant variability in rosacea treatment coverage, with only 10% of states offering unrestricted access to basic therapeutic options, in an analysis of ...
With so many options available, it’s important to consult your doctor to understand how each treatment works and to determine the best options to treat your condition. Topical treatments are ...
The company’s pipeline products include TP-03, TP-04 and TP-05. Its pipeline treats meibomian gland disease, rosacea disease, lyme disease and malaria. Tarsus Pharmaceuticals also carries out Xdemvy ...